The research team identified Staphylococcus aureus in 3% of animal samples, with 18% of them methicillin-resistant.
The proportion of MRSA isolates declined significantly from 2010 through 2019, but resistance to non–beta-lactam antibiotics rose, particularly in southern states.
The intervention involved use of an antiseptic soap and nasal ointment on patients in a network of hospitals, nursing homes, and long-term care facilities.
Data collected from 29 European countries revealed interactions between age, sex, and resistant bloodstream infections.
Data on Salmonella and Campylobacter bacteria from people and food-producing animals show high levels of resistance to commonly used antibiotics.
A review of randomized controlled trials found that Asian and Black participants were underrepresented.
The study highlights the impact of community COVID-19 incidence on racial disparities in invasive Staphylococcus aureus infections.
The studies examined trends in hospitalized patients, and the authors said the findings support the need for better infection-prevention strategies in the region.
A trial found that mupirocin was more effective than iodophore in reducing Staphylococcus aureus in ICU patients.
A phase 3 trial shows ceftobiprole was noninferior to daptomycin in patients with complicated Staphylococcus aureus bacteremia.
